Ischemic heart disease decisions — 2025

The Board granted an initial rating of 100 percent for the service-connected coronary artery disease (CAD) with stent placement, effective from July 25, 2025.

The appeal for service connection for coronary artery disease (CAD) to include myocardial infarction (MI) was withdrawn by the Veteran and granted in full.

The Veteran withdrew the appeal of all issues, and the Board has no jurisdiction to review these appeals.

The Board remands the matter to obtain additional private treatment records and a VA examination to determine if the Veteran's service-connected PTSD caused or aggravated his death.

The Board granted an effective date of August 9, 2023 for the award of service connection and increased ratings for several conditions, but remanded claims for higher initial disability ratings.

The appeal of the claim for service connection for keratoderma is dismissed as moot. Service connection was granted for several conditions, and effective dates were assigned.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board denied service connection for a foot disability, heart disability, upper digestive disability, and erectile dysfunction as the evidence did not support a finding that these conditions were related to the Veteran's active military service.

The Veteran is granted SMC at a higher level pursuant to 38 U.S.C. § 1114(r)(1) due to the severity of his service-connected conditions, specifically Alzheimer's disease with frontotemporal dementia.

The Board granted a separate initial 20 percent rating for right knee meniscal tear based on limitation of knee flexion, and an initial 60 percent rating for arteriosclerotic heart disease. It also granted TDIU due to service-connected residuals of prostate cancer.

The Board denied service connection for a heart condition, systemic lupus erythematosus (lupus), and tinnitus as the evidence did not support a finding of a connection between these conditions and the Veteran's military service.

The Board denied the Veteran's claims for an initial compensable rating for cirrhosis of the liver and service connection for a heart condition, but granted service connection for bilateral hearing loss.

The Board granted readjudication of the claim for service connection for the cause of the Veteran's death due to new and relevant evidence being submitted after the prior denial.

The Board granted an earlier effective date of September 1, 2015 for the award of service connection for coronary artery disease status post myocardial infarction based on presumptive service connection due to herbicide exposure during Vietnam service.

The Board denied service connection for chronic sinusitis, hyperlipidemia, diabetes mellitus, type II, diabetic retinopathy, erectile dysfunction, kidney cancer, and coronary artery disease.

The Board remands the claims for service connection for hypertension and coronary artery disease as secondary to hypertension due to an inadequate VA examination and potential outstanding relevant VA treatment records.

The appeal for an earlier effective date prior to April 26, 2021 for service connection for coronary artery disease (CAD) is dismissed as the Board decision was a purely ministerial implementation of its own previous decision.

The appeal for service connection for an acquired psychiatric disorder and the readjudication of the claim for coronary artery disease (CAD) are dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted service connection for diabetes mellitus type II, hypertension, and atherosclerotic heart disease based on presumed exposure to herbicides. Erectile dysfunction was also granted as secondary to the service-connected hypertension. Hand tremors were denied.

The Board denied an initial rating in excess of 10 percent for allergic rhinitis and remanded the issue of entitlement to service connection for coronary artery disease.